Medical Devices: Page 5

  • A picture of five Ōura smart rings against a gold background.
    Image attribution tooltip
    Courtesy of Ōura
    Image attribution tooltip

    FDA guidance eases wearables oversight. But experts have questions about what’s next.

    Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.

    By • Jan. 27, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for single-shot pulsed field ablation catheter

    Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.

    By • Jan. 26, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Two clinicians wearing scrubs stand in front of Intuitive Surgical's da Vinci 5 robotic surgery system.
    Image attribution tooltip
    Courtesy of Tampa General Hospital
    Image attribution tooltip

    Intuitive’s cardiac initiative includes valve repair, LAA closure

    With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.

    By • Jan. 26, 2026
  • A surgeon sits at the console of a da Vinci 5 robot while another medical professional works in the background.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Intuitive pushes into cardiac robotic surgery, ASCs

    The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.

    By • Jan. 23, 2026
  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Integra recalls wound and burn devices amid reports of serious injuries

    Packaging failures could lead to breaches in the sterile barrier and patient infections.

    By • Jan. 23, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • A person sits in a white chair and looks to the side.
    Image attribution tooltip
    Elise Reuter/MedTech Dive, data from MedTech Dive
    Image attribution tooltip

    AdvaMed leaders on tariffs, MDUFA and wearables

    AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

    By • Jan. 22, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s cardiovascular business boosts medtech growth in 2025

    Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.

    By • Jan. 21, 2026
  • An artificial heart valve is pictured against a white background.
    Image attribution tooltip
    Retrieved from Anteris Technologies Global on January 21, 2026
    Image attribution tooltip

    Medtronic to buy up to $90M stake in heart valve developer Anteris

    Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

    By • Jan. 21, 2026
  • Professional photo of Jim Hollingshead
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    BVI appoints Jim Hollingshead as CEO

    Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.

    By • Jan. 21, 2026
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott gets Europe’s CE mark for dual ablation catheter

    The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.

    By • Jan. 20, 2026
  • A commercial building displays a “Boston Scientific” sign on its exterior. The structure features a smooth white facade with reflective windows and minimal architectural detailing, set against a partly cloudy sky.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    3 takeaways from Boston Scientific’s $14.5B Penumbra deal

    Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.

    By • Jan. 20, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific recalls stent over issue linked to 3 deaths

    The company said the deaths were associated with off-label or investigational use of the device.

    By • Jan. 20, 2026
  • Intuitive Surgical's da Vinci 5 robotic surgery system is shown against a white background.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Intuitive says general surgery, acute care fuel US robot momentum

    CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

    By • Jan. 16, 2026
  • A portrait of a smiling person dressed in business attire on a white background.
    Image attribution tooltip
    Permission granted by Staar Surgical
    Image attribution tooltip

    STAAR CEO exits after company rejects Alcon buyout

    An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.

    By • Jan. 16, 2026
  • A close-up image of an Nvidia chip on a computer motherboard.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Trump issues 25% tariffs on narrow range of semiconductors

    The levies, effective Jan. 15, do not cover products used for data centers and consumer applications, per a proclamation signed Wednesday.

    By Antone Gonsalves , Phil Neuffer • Jan. 15, 2026
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to acquire Penumbra for $14.5B

    With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

    By • Jan. 15, 2026
  • Two gloved hands hold a flexible yellow strip with small dots on one end.
    Image attribution tooltip
    Courtesy of Precision Neuroscience
    Image attribution tooltip

    Medtronic inks deal to build brain computer interface into surgical system

    Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation system.

    By • Jan. 15, 2026
  • A person speaks at a podium.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip
    Deep Dive

    5 topics to watch as MDUFA negotiations restart

    The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.

    By • Jan. 14, 2026
  • Boston Scientific's Farapoint pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific gains FDA’s OK for new PFA catheter

    The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.

    By • Jan. 14, 2026
  • Three stacked wooden cubes on the right side of the frame read "M&A"
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Smith & Nephew to acquire Integrity Orthopaedics for up to $450M

    The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff repair system.

    By • Jan. 14, 2026
  • A person sits on a ledge with their legs in the water and eats. A patch is on their arm and a pen is on the ground next to food.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic gets FDA clearance for smart insulin pen app

    The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.

    By • Jan. 13, 2026
  • A picture of Inspire Medical Systems' patient app and remote.
    Image attribution tooltip
    Courtesy of Inspire Medical Systems
    Image attribution tooltip

    Inspire appoints Matt Osberg as CFO

    While Osberg joins Inspire without prior medtech experience, CEO Tim Herbert says the new CFO can help take the company “to the next level.”

    By • Jan. 13, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy incontinence device maker Valencia

    The deal would set up Boston Scientific to compete with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.

    By • Jan. 12, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards calls off JenaValve buyout after court halts deal

    Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.

    By • Jan. 12, 2026